Jørgen Hilden
Associate professor emeritus, Associate Professor emeritus
Section of Biostatistics
Ãster Farimagsgade 5 opg. B, Postboks 2099
1014 København K
Denmark
Member of:
- 2005
- Published
Mål for diagnostiske tests ydeevne
Rud, B., Matzen, P. & Hilden, Jørgen, 2005, In: Ugeskrift for læger. 167, 33, p. 3018-22 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
Jespersen, C. M., Als-Nielsen, B., Damgaard, M., Hansen, J. F., Hansen, S., Helø, O. H., Hildebrandt, P., Hilden, Jørgen, Jensen, G. B., Kastrup, J., Kolmos, H. J., Kjøller, E., Lind, I., Nielsen, H., Petersen, L., Gluud, C. & CLARICOR Trial Group, C. T. G., 2005, In: BMJ - British Medical Journal - Clinical Research Edition. 332, 7532, p. 22-7 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
What properties should an overall measure of test performance possess?
Hilden, Jørgen, 2005, In: Clinical Chemistry. 51, 2, p. 471; author reply 471-2Research output: Contribution to journal › Journal article › Research › peer-review
- 2004
- Published
Diagnostik: nye metodologiske initiativer
Magid, E., Jørgensen, P. E., Jørgensen, L. G., Madsen, J. S., Larsen, T. B. & Hilden, Jørgen, 2004, In: Ugeskrift for læger. 166, 18, p. 1664-6 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Klaringsrapporterne 1996-2001. Lave anførte evidensniveauer for den diagnostiske traefsikkerhed af anbefalede klinisk-biokemiske undersøgelser
Jørgensen, P. E., Madsen, J. S., Jørgensen, L. G., Larsen, T. B., Hilden, Jørgen & Magid, E., 2004, In: Ugeskrift for læger. 166, 18, p. 1667-70 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?
Gronlund, B., Høgdall, Claus Kim, Hilden, Jørgen, Engelholm, S. A., Høgdall, Estrid Vilma Solyom & Hansen, H. H., 2004, In: Journal of Clinical Oncology. 22, 20, p. 4051-8 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2003
- Published
Bollesprøjte-publikation
Hilden, Jørgen, 2003, In: Ugeskrift for læger. 165, 18, p. 1893-4 1 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect measures in biostatistics
Hilden, Jørgen, 2003, In: Journal of Clinical Epidemiology. 56, 4, p. 391-2; author reply 392-3Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Kondom mod hiv: knap så ringe endda
Hilden, Jørgen, 2003, In: Ugeskrift for læger. 165, 16, p. 1693; author reply 1693-4Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Lung cancer in MMVF workers - viewpoints on a null-result study
Hansen, E. S., Klausen, H., Hilden, Jørgen & Rosdahl, N., 2003, In: International Journal of Occupational and Environmental Health. Vol. 9, no.4, p. 397-8Research output: Contribution to journal › Journal article › Research › peer-review
ID: 314941
Most downloads
-
165
downloads
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain
Research output: Contribution to journal › Review › Research › peer-review
Published -
149
downloads
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
140
downloads
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published